Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc (MDGL) Covered Calls
As of September 25, 2026, MDGL has 139 covered call opportunities in the coming three months. Return ranges from 3.8 to 70.0% until expiration. Annualized return ranges from 20.6 to 449.2%. The nearest expiration is October 16, 2026. Maximum potential profit is $36,144.
Read more
Running MDGL covered calls helps you generate consistent income from Madrigal Pharmaceuticals Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Madrigal Pharmaceuticals Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best MDGL covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if MDGL stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling MDGL covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Madrigal Pharmaceuticals Inc covered call is worth writing.
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Income-focused investors, long-term MDGL holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling MDGL covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Madrigal Pharmaceuticals Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile70.63% Elevated
- Market cap (M$)11,935
- 52 weeks high-16.01%
- 52 weeks low31.24%
- Analyst recommendationStrong Buy
1.14 - Target price$682.00
30.99% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-03
- P/E—
- Future P/E81.51
- EPS (ttm)-12.88
- EPS growth next 5 years—
As of September 25, 2026
| 2026-10-16 | 21 | 650.00 | 25.83 | 0.05 | 6.10 | 13349.00 | 25.84 | 449.16 | -0.01 | +0.09 | 8 | 6.05 |
| 2026-10-16 | 21 | 640.00 | 23.90 | 0.05 | 6.00 | 12349.00 | 23.91 | 415.51 | -0.01 | +0.09 | 107 | 5.95 |
| 2026-10-16 | 21 | 610.00 | 18.09 | 0.10 | 3.50 | 9354.00 | 18.11 | 314.74 | -0.02 | +0.07 | 9 | 3.40 |
| 2026-10-16 | 21 | 600.00 | 16.15 | 0.05 | 2.70 | 8349.00 | 16.16 | 280.92 | -0.01 | +0.07 | 472 | 2.65 |
| 2026-11-20 | 56 | 720.00 | 39.38 | 0.05 | 4.60 | 20349.00 | 39.39 | 256.76 | -0.01 | +0.06 | 0 | 4.55 |
| 2026-10-16 | 21 | 590.00 | 14.22 | 0.30 | 6.00 | 7374.00 | 14.28 | 248.12 | -0.06 | +0.12 | 107 | 5.70 |
| 2026-11-20 | 56 | 710.00 | 37.45 | 0.05 | 5.90 | 19349.00 | 37.46 | 244.14 | -0.01 | +0.07 | 0 | 5.85 |
| 2026-11-20 | 56 | 700.00 | 35.51 | 0.05 | 4.50 | 18349.00 | 35.52 | 231.52 | -0.01 | +0.06 | 0 | 4.45 |
| 2026-12-18 | 84 | 780.00 | 51.00 | 0.05 | 8.40 | 26349.00 | 51.01 | 221.64 | -0.01 | +0.08 | 46 | 8.35 |
| 2026-11-20 | 56 | 690.00 | 33.58 | 1.10 | 4.90 | 17454.00 | 33.79 | 220.23 | -0.21 | +0.08 | 0 | 3.80 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best MDGL covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→